Imatinib resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss of TP53 but without BCR/ABL kinase domain mutation in chronic myelogenous leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss of TP53 but without BCR/ABL kinase domain mutation in chronic myelogenous leukemia

Published:2008-05 Issue:1 Volume:183 Page:77-81
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Yamamoto Katsuya,Yakushijin Kimikazu,Nishikawa Shinichiro,Minagawa Kentaro,Katayama Yoshio,Shimoyama Manabu,Matsui Toshimitsu

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference14 articles.

1. The biology of chronic myeloid leukemia;Faderl;N Engl J Med,1999

2. Chronic myeloid leukemia: advances in biology and new approaches to treatment;Goldman;N Engl J Med,2003

3. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia;Johansson;Acta Haematol,2002

4. ISCN 2005: an international system for human cytogenetic nomenclature (2005),2005

5. F-SSCP: fluorescence-based polymerase chain reaction–single-strand conformation polymorphism (PCR-SSCP) analysis;Makino;PCR Methods Appl,1992

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl;Cancer Research;2010-09-28

2. Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents;Current Cancer Drug Targets;2009-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP